http://www.nationalboardinstitute.com/members/cakesing95/activity/ Activity feed for Glerup. Fri, 23 May 2025 17:06:54 -0700 https://buddypress.org/?v=9.1.1 en-US 30 hourly 2 d5fa2be5f65424508fd2142cb8240c47 http://www.nationalboardinstitute.com/activity/p/43042/ Sun, 09 Feb 2025 12:50:18 -0800 Implications for clinical intervention include recognizing that assaults involving substance use and force are traumatic and warrant individualized treatment.Hepatitis C virus and alcoholic liver disease are major causes of chronic liver diseases worldwide. Little is known about differences between chronic hepatitis C and alcoholic liver disease…[Read more]

]]> 0 d0debf5eacdef1b1614798ddf0e2dd60 http://www.nationalboardinstitute.com/activity/p/39425/ Wed, 05 Feb 2025 13:33:36 -0800 Studying generalisation of associative learning requires analysis of response gradients measured over a continuous stimulus dimension. In human studies, there is often a high degree of individual variation in the gradients, making it difficult to draw conclusions about group-level trends with traditional statistical methods. Here, we demonstrate a…[Read more]

]]> 0 a94a9331d1cf0dfd42185c7aeab4f243 http://www.nationalboardinstitute.com/activity/p/38718/ Tue, 04 Feb 2025 13:04:45 -0800 Hypotension, hypoxia, and altered mental status on admission were also associated with poor outcome. CRP > 8.0 mg/dL was strongly associated with MV/HFNC (odds ratio, 26.31; 95% confidence interval, 7.78-88.92; P less then 0.001), and showed better diagnostic characteristics compared to commonly used clinical scores. Conclusion Patients aged ≥ 8…[Read more]

]]> 0 93021180d9289d71bedd6a646ffc35e2 http://www.nationalboardinstitute.com/activity/p/37819/ Mon, 03 Feb 2025 12:29:43 -0800 Availability GLASSGo is available at https//github.com/lotts/GLASSgo/ under the MIT license and is accompanied by instruction and application data. Furthermore, it can be installed into any Galaxy instance using the Galaxy ToolShed.Importance Early-stage chronic kidney disease (CKD) characterized by microalbuminuria is associated with future…[Read more]

]]> 0 f653742c3f538f0683d1d653147e4080 http://www.nationalboardinstitute.com/activity/p/36897/ Sun, 02 Feb 2025 12:35:47 -0800 Completeness of final reports increased from 39.5% to 45.4% (P = .04). click here The workload for tumor board preparation and discussion did not change significantly. Standardized tumor board reports included 50% (61/122) of the data items carried in the NCR. An automated process was developed to upload information captured in tumor board reports…[Read more]

]]> 0 73ee1b4971b74081618be0b901e74457 http://www.nationalboardinstitute.com/activity/p/36030/ Sat, 01 Feb 2025 12:30:24 -0800 Allogeneic islet transplantation is limited by adverse effects of chronic immunosuppression used to control rejection. The programmed cell death 1 pathway as an important immune checkpoint has the potential to obviate the need for chronic immunosuppression. We generated an oligomeric form of programmed cell death 1 ligand chimeric with core…[Read more]

]]> 0 77819b01c71bb094017da7c8bc1191fa http://www.nationalboardinstitute.com/activity/p/35073/ Fri, 31 Jan 2025 13:01:23 -0800 The search for new nanostructural topologies composed of elemental carbon is driven by technological opportunities as well as the need to understand the structure and evolution of carbon materials formed by planetary shock impact events and in laboratory syntheses. We describe two new families of diamond-graphene (diaphite) phases constructed from…[Read more]

]]> 0 1546f41e8735193136d3fa6daa3e24b6 http://www.nationalboardinstitute.com/activity/p/34298/ Thu, 30 Jan 2025 12:36:27 -0800 ferentiate between periodized fluctuations in load.Weakley, J, Chalkley, D, Johnston, R, García-Ramos, A, Townshend, A, Dorrell, H, Pearson, M, Morrison, M, and Cole, M. Criterion validity, and interunit and between-day reliability of the FLEX for measuring barbell velocity during commonly used resistance training exercises. J Strength Cond Res…[Read more]

]]> 0 093f35377d7e4d66dbd17bf2fe77a1de http://www.nationalboardinstitute.com/activity/p/31338/ Tue, 28 Jan 2025 16:45:42 -0800 4%) withdrew from TOP. Median time on natalizumab was 3.3 (range 0-11.6) years; median follow-up time was 5.2 (range 0-10.8) years. The on-natalizumab ARR was 0.15, a 92.5% reduction from the year before initiation. Ten-year cumulative probabilities of disability worsening and improvement were 27.8% and 33.1%, respectively. On-natalizumab ARRs…[Read more]

]]> 0 27956008d2cd0241fc973a16f370de07 http://www.nationalboardinstitute.com/activity/p/31305/ Tue, 28 Jan 2025 16:42:35 -0800 0